
|Articles|March 1, 2007
FDA grants orphan status to two Lux products
The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
2
How screen time and eyelid health affect dry eye risk
3
ESCRS 2026: Ultra-widefield imaging in paediatric eye care
4
ESCRS 2026: Why surgeons should be willing to use what they prescribe to patients
5












